Succimer Fails to Remove Mercury From Body

A new study indicates the FDA-approved lead treatment does not effectively eliminate mercury in children.

Updated on Oct. 20, 2026 in Autism

Bold flat-color editorial illustration of a laboratory funnel and beaker, representing medical analysis and research findings. — A new study concludes that the FDA-approved lead-poisoning medication succimer is ineffective at reducing mercury levels in children. AI Illustration. Upload story photo >

Live Poll

Do you trust scientific research when considering alternative medical treatments for your family?

Researchers have determined that succimer, a medication used for lead poisoning, fails to effectively remove mercury from the body. The study found that succimer produced only an 18 percent difference in mercury levels, despite its 42 percent impact on blood lead levels.

Why it matters

The findings are significant because some families have turned to succimer as an alternative therapy for autism. Understanding that the drug is not an effective mercury chelator is crucial for parents and healthcare providers evaluating treatment options.

The study analyzed blood samples from 767 children and found succimer produced an 18 percent difference in blood mercury levels compared to a 42 percent reduction in lead levels. Researchers utilized data from the Treatment of Lead-exposed Children trial.

The players

Food and Drug Administration

The federal agency is responsible for protecting public health by ensuring the safety and efficacy of human and veterinary drugs.

The details

Researchers measured mercury concentrations before treatment, one week after intervention, and following three month-long courses of the drug. While the FDA has approved succimer for lead poisoning, it has not approved the treatment for mercury reduction.

One week after treatment, researchers observed a small change in mercury blood concentrations.
After five months of continued therapy, researchers noted that the treatment slowed mercury accumulation.

Health Landscape

This study builds upon the methodology of the Treatment of Lead-exposed Children trial to re-evaluate the clinical utility of chelation drugs. By revisiting existing data, researchers are clarifying the limitations of using lead-poisoning treatments for other heavy metal exposures.

Families considering alternative therapies for autism should be aware that succimer is not an approved or effective treatment for mercury removal. Patients and caregivers should consult with medical professionals regarding safe and evidence-based treatment options.

The takeaway

This study confirms that medical treatments for lead poisoning should not be used off-label for mercury removal. Families should rely on clinical evidence before pursuing alternative therapies for neurological conditions.